Exai Bio

Exai Bio Appoints Dave Daly as Chief Executive Officer

Exai to accelerate product development and partnering of its novel oncRNA- and generative AI-based liquid biopsy platform Dave Daly brings more than 30 years of extensive cancer diagnostics and executive leadership experience PALO ALTO, Calif. – Exai Bio, a next-generation oncRNA- and generative AI-based liquid biopsy company, today announced the appointment of Dave Daly as Chief Executive Officer. With more than 30 years of cancer … Continue reading Exai Bio Appoints Dave Daly as Chief Executive Officer

Broken String Biosciences

Broken String Biosciences Appoints Steve Becker as Chief Commercial Officer

Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets CAMBRIDGE, England – Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has appointed Steve Becker as Chief Commercial Officer. An experienced global life sciences executive, Steve will guide the expansion of … Continue reading Broken String Biosciences Appoints Steve Becker as Chief Commercial Officer

enGene

enGene Announces Appointment of Ron Cooper as Chief Executive Officer

Ron Cooper succeeds Jason Hanson as Chief Executive Officer and Director Company also announces Dr. Raj Pruthi’s promotion to Chief Medical Officer BOSTON & MONTREAL – enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage genetic medicines company whose non-viral, intravesical lead product candidate, EG-70, is in a pivotal study for BCG-unresponsive high-risk Non-Muscle Invasive Bladder Cancer (NMIBC), today announced that Ron Cooper … Continue reading enGene Announces Appointment of Ron Cooper as Chief Executive Officer

Orthobond

Orthobond Expands its Board of Directors with Appointment of Eric Major as Chairman

Expansion of the Board and the company’s recent FDA Clearance marks the beginning of Orthobond’s commercialization phase PRINCETON, N.J. – Orthobond Corporation, a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, today publicly announced the appointment of Eric Major as the company’s Chairman of the Board. “We are pleased to be expanding Orthobond’s Board of Directors with the appointment … Continue reading Orthobond Expands its Board of Directors with Appointment of Eric Major as Chairman

CEL-SCI

CEL-SCI Appoints Robert Watson as Chairperson of the Board

VIENNA, Va. – CEL-SCI Corporation (NYSE American: CVM) today announced that Robert (“Bob”) Watson, who has served as a Director of the Company since 2017, has been appointed Chairperson of the Board. Bob is an accomplished business leader who began his career as an investment banker. With over four decades of experience across various healthcare markets, Bob brings extensive expertise in capital formation strategies and partnerships to … Continue reading CEL-SCI Appoints Robert Watson as Chairperson of the Board